SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020839
Filing Date
2023-05-11
Accepted
2023-05-11 07:26:57
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20230331.htm   iXBRL 10-Q 2439625
2 EX-31.1 dyn-ex31_1.htm EX-31 15108
3 EX-31.2 dyn-ex31_2.htm EX-31 14553
4 EX-32.1 dyn-ex32_1.htm EX-32 7713
5 EX-32.2 dyn-ex32_2.htm EX-32 7595
  Complete submission text file 0000950170-23-020839.txt   7287320

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20230331_def.xml EX-101.DEF 111290
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20230331_lab.xml EX-101.LAB 330406
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20230331.xsd EX-101.SCH 34199
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20230331_cal.xml EX-101.CAL 34609
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20230331_pre.xml EX-101.PRE 242138
48 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20230331_htm.xml XML 1357494
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 23908821
SIC: 2834 Pharmaceutical Preparations